Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: The 336 merged reexam decision

Yes, they know what prior art is mentioned, but have not idea whether any of it will be the cause for a rejection. Why assume the need for an ammendment if none is needed? Wouldn't the patent owner be indicating where he thought a weakness was by acting first? Appreciate your thoughts. Thanks Opty

1
Jun 23, 2008 01:47PM
3
Jun 23, 2008 01:52PM
1
Jun 23, 2008 01:57PM
2
Jun 23, 2008 01:59PM
6
Jun 23, 2008 02:23PM

Jun 23, 2008 02:44PM
3
Jun 23, 2008 02:53PM

Jun 23, 2008 03:25PM
3
Jun 23, 2008 03:30PM

Jun 23, 2008 05:26PM
1
Jun 23, 2008 06:33PM
4
Jun 23, 2008 08:54PM
2
Jun 24, 2008 04:12AM
5
Jun 24, 2008 06:22AM
3
Jun 24, 2008 06:40AM
5
Jun 24, 2008 06:46AM
3
Jun 24, 2008 07:05AM
2
Jun 24, 2008 07:09AM
5
Jun 24, 2008 07:19AM
2
Jun 24, 2008 07:28AM
4
Jun 24, 2008 07:45AM
3
Jun 24, 2008 08:14AM
2
Jun 24, 2008 08:29AM
Share
New Message
Please login to post a reply